Table 1 Demographic and clinical characteristics of the study participants.

From: Examining the complex Interplay between gut microbiota abundance and short-chain fatty acid production in amyotrophic lateral sclerosis patients shortly after onset of disease

Characteristics

ALS total group (n = 16)

Control group (n = 12)

p-value

 

Spinal ALS (n = 11)

Bulbar ALS (n = 5)

  

Age (years)

64,59 ± 10,52

66,6 ± 9,84

67,6 ± 7,16

0.14a

Sex

    

Male

54,54%

40%

44,44%

0.1b

Female

45,45%

60%

55,55%

Family history

    

Yes

0%

0%

−

 

No

100%

100%

−

 

Duration of Disease (months)1

65,63 ± 38

42,6 ± 24,93

−

0.23c

ALS Functional Rating Scale-Revised

27 ± 11,80

36 ± 8,18

−

0.14c

El Escorial criteria

    

Definite

9%

40%

−

< 0,0001b

Probable

27%

20%

−

Probable, lab supported

0%

40%

−

Possible

36%

0%

− 

Missing

27%

0%

−

  1. 1For age, Duration of Disease, and ALS-FR data shown is mean ± SD. Duration of Disease refers to entire duration of pathology (i.e. from debut to end). Test employed for evaluating differences: aANOVA, bFisher’s exact test, cUnpaired t test.
Back to article page